Pasithea Therapeutics (KTTA) Payables (2021 - 2024)
Historic Payables for Pasithea Therapeutics (KTTA) over the last 4 years, with Q3 2024 value amounting to $660397.0.
- Pasithea Therapeutics' Payables fell 6467.44% to $660397.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $660397.0, marking a year-over-year decrease of 6467.44%. This contributed to the annual value of $2.6 million for FY2023, which is 7229.46% up from last year.
- According to the latest figures from Q3 2024, Pasithea Therapeutics' Payables is $660397.0, which was down 6467.44% from $1.4 million recorded in Q2 2024.
- In the past 5 years, Pasithea Therapeutics' Payables registered a high of $2.6 million during Q4 2023, and its lowest value of $433684.0 during Q1 2022.
- Over the past 4 years, Pasithea Therapeutics' median Payables value was $1.4 million (recorded in 2024), while the average stood at $1.4 million.
- Its Payables has fluctuated over the past 5 years, first skyrocketed by 29467.49% in 2023, then plummeted by 6467.44% in 2024.
- Quarter analysis of 4 years shows Pasithea Therapeutics' Payables stood at $447280.0 in 2021, then surged by 231.2% to $1.5 million in 2022, then skyrocketed by 72.29% to $2.6 million in 2023, then tumbled by 74.13% to $660397.0 in 2024.
- Its last three reported values are $660397.0 in Q3 2024, $1.4 million for Q2 2024, and $2.4 million during Q1 2024.